Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	97
Overall Study	STARTED	GEn (XP13512/GSK1838262) 600 mg	115
Overall Study	STARTED	GEn (XP13512/GSK1838262) 1200 mg	113
Overall Study	Safety Population	Placebo	96
Overall Study	Safety Population	GEn (XP13512/GSK1838262) 600 mg	115
Overall Study	Safety Population	GEn (XP13512/GSK1838262) 1200 mg	111
Overall Study	Modified Intent-to-Treat Population	Placebo	96
Overall Study	Modified Intent-to-Treat Population	GEn (XP13512/GSK1838262) 600 mg	114
Overall Study	Modified Intent-to-Treat Population	GEn (XP13512/GSK1838262) 1200 mg	111
Overall Study	COMPLETED	Placebo	77
Overall Study	COMPLETED	GEn (XP13512/GSK1838262) 600 mg	104
Overall Study	COMPLETED	GEn (XP13512/GSK1838262) 1200 mg	98
Overall Study	NOT COMPLETED	Placebo	20
Overall Study	NOT COMPLETED	GEn (XP13512/GSK1838262) 600 mg	11
Overall Study	NOT COMPLETED	GEn (XP13512/GSK1838262) 1200 mg	15

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00365352/flow